GlassScriptPhysician profile
James Cahill
NPI 1316529738
$608.26
in general payments reported to CMS, 2019-2025
7 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.61 · 2024: $260 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $150.02 | 2023-2024 | Motionsense Digital Goniometer, Mako |
| Alkermes, INC. | $141.53 | 2023-2025 | Aristada, Aristada Initio, Vivitrol |
| Anika Therapeutics, INC. | $140.93 | 2025 | Tactoset, Integrity Implant |
| Janssen Pharmaceuticals, INC | $92.46 | 2024-2025 | Spravato, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $44.60 | 2024-2025 | Rexulti, Abilify Asimtufii |
| Tempus Ai, INC | $19.90 | 2024 | |
| Lundbeck LLC | $18.82 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.